Background and Aims: We aimed to evaluate the pattern of lipid-lowering-therapies
(LLT) use and the achievement of LDL-c targets in patients with Type 2 diabetes (T2D)
in the Italian diabetes specialist clinical practice.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to AtherosclerosisAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
308 / #915 Poster SAAG: LIPID-LOWERING THERAPIES 10-07-2020 12:00 PM - 1:00 PM
Identification
Copyright
© 2020 Published by Elsevier Inc.
